 Each vaccine consist of a mixture of 17,6.106 melanoma cells, from four melanoma cell lines, not genetically modified and lethally irradiated. As adjuvant BCG 120 μg prot the first day and rHuGM-CSF Molgramostim, 400 μg, fractionated in four days doses will be used. 